Breathe BioMedical Statistics
Total Valuation
BRTH has a market cap or net worth of $57.36 million. The enterprise value is $57.90 million.
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
BRTH has 11.47 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 11.47M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 475.22 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 19.10 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -6,075.51% and return on invested capital (ROIC) is -325.59%.
Return on Equity (ROE) | -6,075.51% |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | -325.59% |
Revenue Per Employee | n/a |
Profits Per Employee | -$293,783 |
Employee Count | 26 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | n/a |
Average Volume (20 Days) | n/a |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -7.90M |
Pretax Income | -7.33M |
Net Income | -7.64M |
EBITDA | n/a |
EBIT | n/a |
Earnings Per Share (EPS) | -$0.67 |
Full Income Statement Balance Sheet
The company has $1.76 million in cash and $2.31 million in debt, giving a net cash position of -$543,631 or -$0.05 per share.
Cash & Cash Equivalents | 1.76M |
Total Debt | 2.31M |
Net Cash | -543,631 |
Net Cash Per Share | -$0.05 |
Equity (Book Value) | 120,699 |
Book Value Per Share | 0.01 |
Working Capital | n/a |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$4.29 million and capital expenditures -$563,125, giving a free cash flow of -$4.86 million.
Operating Cash Flow | -4.29M |
Capital Expenditures | -563,125 |
Free Cash Flow | -4.86M |
FCF Per Share | -$0.42 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |